LONG-TERM METERED-DOSE INHALER ADHERENCE IN A CLINICAL-TRIAL

被引:138
|
作者
RAND, CS
NIDES, M
COWLES, MK
WISE, RA
CONNETT, J
机构
[1] JOHNS HOPKINS UNIV, SCH MED, DIV PULM & CRIT CARE MED, BALTIMORE, MD 21218 USA
[2] UNIV CALIF LOS ANGELES, SCH MED, LOS ANGELES, CA 90024 USA
[3] UNIV MINNESOTA, DIV BIOSTAT, MINNEAPOLIS, MN 55455 USA
[4] CASE WESTERN RESERVE UNIV, CLEVELAND, OH 44106 USA
[5] HENRY FORD HOSP, DETROIT, MI 48202 USA
[6] MAYO CLIN, ROCHESTER, MN USA
[7] OREGON HLTH SCI UNIV, PORTLAND, OR 97201 USA
[8] UNIV ALABAMA, BIRMINGHAM, AL USA
[9] UNIV MANITOBA, WINNIPEG, MB R3T 2N2, CANADA
[10] UNIV MINNESOTA, CTR COORDINATING, MINNEAPOLIS, MN 55455 USA
[11] UNIV MIAMI, CORAL GABLES, FL 33124 USA
[12] UNIV PITTSBURGH, PITTSBURGH, PA 15260 USA
[13] UNIV UTAH, SALT LAKE CITY, UT 84112 USA
[14] NHLBI, DIV LUNG DIS, BETHESDA, MD USA
关键词
D O I
10.1164/ajrccm.152.2.7633711
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Poor adherence to medication regimens is a well-documented phenomenon in clinical practice and an ever-present concern in clinical trials. Little is known about adherence to inhaled medication regimens over extended periods. The present paper describes the 2-yr results of the Lung Health Study (LHS) program, which was developed to maintain long-term adherence to an inhaled medication regimen in 3,923 special intervention participants (as measured by self-report and medication canister weight). The LHS is a double-blind, multicenter, randomized controlled clinical trial of smoking intervention and bronchodilator therapy (ipratropium bromide or placebo) for early intervention in chronic obstructive pulmonary disease (COPD). At the first 4-mo follow-up visit, nearly 70% of participants reported satisfactory or better adherence. Over the next 18 mo, self-reported satisfactory or better adherence declined to about 60%. Canister weight classified adherence as satisfactory or better in 72% of participants returning all canisters at 1 yr, and in 70% of the participants returning all canisters at the 2-yr follow-up. Self-reporting confirmed by canister weight classified 48% of participants at 1 yr as showing satisfactory or better adherence. Overusers were 50% more likely than others to misrepresent their true smoking status, suggesting that canister weights indicating overuse may be deceptive. Results of multiple logistic regression analysis indicate that the best compliance was found in participants who were married, older, white, had more severe airways obstruction, less shortness of breath, and fewer hospitalizations, and who had not been confined to bed for respiratory illnesses. In summary, a structured program for promoting adherence to an inhaled medication regimen was successful in achieving initial satisfactory adherence in the majority of participants; however, adherence declined notably from the conclusion of this program to the first-year follow-up, and more gradually over the second year.
引用
收藏
页码:580 / 588
页数:9
相关论文
共 50 条
  • [21] Long-term safety and efficacy studies of epinephrine HFA metered-dose inhaler (Primatene® Mist): a two-stage randomized controlled trial
    Kerwin, Edward M.
    Tashkin, Donald P.
    Korenblat, Phillip E.
    Greos, Leon S.
    Pearlman, David S.
    Bensch, George W.
    Miller, S. David
    Marrs, Tony
    Luo, Mary Z.
    Zhang, Jack Y.
    JOURNAL OF ASTHMA, 2021, 58 (05) : 633 - 644
  • [22] PROCATEROL METERED-DOSE INHALER IN THE TREATMENT OF ASTHMA
    STORMS, W
    BODMAN, S
    NATHAN, R
    WILSON, JM
    ANNALS OF ALLERGY, 1985, 54 (04): : 338 - 338
  • [23] Systemic bioavailability and long-term systemic effects of budesonide and formoterol pressurized metered-dose inhaler in asthma patients.
    Shah, S. R.
    Peters, S. P.
    Gillen, M.
    Martin, P.
    O'Brien, C. D.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (01) : A29 - A29
  • [24] Budesonide/formoterol pressurized metered-dose inhaler
    Lyseng-Willianison, Katherine A.
    Simpson, Dene
    DRUGS, 2008, 68 (13) : 1855 - 1864
  • [25] PROCATEROL METERED-DOSE INHALER IN ADULTS WITH ASTHMA
    STORMS, WW
    BODMAN, SF
    NATHAN, RA
    WILSON, JM
    ANNALS OF ALLERGY, 1985, 55 (03): : 476 - 478
  • [26] Budesonide/Formoterol Pressurized Metered-Dose Inhaler
    Katherine A. Lyseng-Williamson
    Dene Simpson
    Drugs, 2008, 68 : 1855 - 1864
  • [27] METERED-DOSE INHALER AND NEBULIZER IN ACUTE ASTHMA
    LIN, YZ
    HSIEH, KH
    ARCHIVES OF DISEASE IN CHILDHOOD, 1995, 72 (03) : 214 - 218
  • [28] Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients
    Peters, Stephen P.
    Prenner, Bruce M.
    Mezzanotte, William S.
    Martin, Paula
    O'Brien, Christopher D.
    ALLERGY AND ASTHMA PROCEEDINGS, 2008, 29 (05) : 499 - 516
  • [29] Comparison of Easyhaler® metered-dose, dry powder inhaler and a pressurised metered-dose inhaler plus spacer in the treatment of asthma in children
    Juntunen-Backman, K
    Kajosaari, M
    Laurikainen, K
    Malinen, A
    Kaila, M
    Mustala, L
    Kaski, U
    Linna, O
    Marenk, M
    Toivanen, P
    CLINICAL DRUG INVESTIGATION, 2002, 22 (12) : 827 - 835
  • [30] CLINICAL AND INVITRO STUDIES OF INADEQUATE METERED-DOSE INHALER (MDI) USE
    SCHECKER, MH
    WILSON, AF
    NOVEY, HS
    SAVARIRAYAN, S
    MUKAI, D
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 89 (01) : 333 - 333